Advancing Multi-Organ Health: Insights into the Gut–Liver, Gut–Kidney, and Gut–Lung Axis
The gastrointestinal system is increasingly recognized as a central regulator of systemic health, extending its influence far beyond digestion. Scientific advancements in the study of the gut–liver, gut–kidney, and gut–lung axes have revealed complex, bidirectional interactions that play a critical role in the pathogenesis and management of various chronic diseases.
The 16th World Probiotics, Nutrition, Gut Health Conference and Exhibition, scheduled for December 10–11, 2026, in Kuala Lumpur, Malaysia, will feature Track 14: Gut–Liver, Gut–Kidney, and Gut–Lung Axis, dedicated to exploring these vital interconnections and their clinical implications.
Gut–Liver Axis
The gut and liver are closely linked through the portal circulation, enabling continuous exchange of metabolites, microbial components, and signaling molecules. Disruptions in gut microbiota composition have been associated with liver disorders, including non-alcoholic fatty liver disease (NAFLD), fibrosis, and cirrhosis. Current research highlights the potential of probiotics and targeted nutritional strategies in restoring microbial balance and supporting liver function.
Gut–Kidney Axis
The gut–kidney axis has emerged as a key area of interest in the context of chronic kidney disease (CKD). Altered gut microbiota can contribute to the production of uremic toxins, which accumulate due to impaired renal clearance and promote systemic inflammation. Therapeutic modulation of the gut microbiome presents a promising approach to mitigating disease progression and improving patient outcomes.
Gut–Lung Axis
The gut–lung axis represents a rapidly evolving field, with growing evidence supporting the role of gut microbiota in regulating immune responses within the respiratory system. This interaction is particularly relevant in conditions such as asthma, chronic obstructive pulmonary disease (COPD), and respiratory infections. Microbiome-based interventions are being investigated for their potential to enhance immune resilience and reduce inflammation.
Significance of the Track
Track 14 offers a comprehensive platform for scientific exchange, focusing on:
Mechanistic insights into gut-organ communication
Identification of biomarkers and diagnostic approaches
Development of probiotic and nutritional interventions
Advances in clinical and translational microbiome research
Participation Opportunities
Researchers, clinicians, and healthcare professionals are encouraged to engage with this specialized track and contribute to the evolving landscape of microbiome science.
Conference Website:
https://probiotics-guthealth.utilitarianconferences.com/
Abstract Submission:
https://probiotics-guthealth.utilitarianconferences.com/submit-abstract
Registration:
https://probiotics-guthealth.utilitarianconferences.com/registration
WhatsApp Support:
https://wa.me/+971551792927
Track 14 underscores the growing importance of the gut microbiome in multi-organ health, offering valuable insights into innovative therapeutic strategies and future directions in clinical research.
#Probiotics #GutHealth #Microbiome #GutLiverAxis #GutKidneyAxis #GutLungAxis #NutritionScience #ClinicalResearch #HealthcareInnovation #MedicalConference #KualaLumpur #GlobalHealth #Immunology #ChronicDisease #ScientificResearch

Comments
Post a Comment